排序方式: 共有5条查询结果,搜索用时 0 毫秒
1
1.
Ahmed M. Omer Zyta M. Ziora Tamer M. Tamer Randa E. Khalifa Mohamed A. Hassan Mohamed S. Mohy-Eldin Mark A. T. Blaskovich 《Molecules (Basel, Switzerland)》2021,26(2)
An effective drug nanocarrier was developed on the basis of a quaternized aminated chitosan (Q-AmCs) derivative for the efficient encapsulation and slow release of the curcumin (Cur)-drug. A simple ionic gelation method was conducted to formulate Q-AmCs nanoparticles (NPs), using different ratios of sodium tripolyphosphate (TPP) as an ionic crosslinker. Various characterization tools were employed to investigate the structure, surface morphology, and thermal properties of the formulated nanoparticles. The formulated Q-AmCs NPs displayed a smaller particle size of 162 ± 9.10 nm, and higher surface positive charges, with a maximum potential of +48.3 mV, compared to native aminated chitosan (AmCs) NPs (231 ± 7.14 nm, +32.8 mV). The Cur-drug encapsulation efficiency was greatly improved and reached a maximum value of 94.4 ± 0.91%, compared to 75.0 ± 1.13% for AmCs NPs. Moreover, the in vitro Cur-release profile was investigated under the conditions of simulated gastric fluid [SGF; pH 1.2] and simulated colon fluid [SCF; pH 7.4]. For Q-AmCs NPs, the Cur-release rate was meaningfully decreased, and recorded a cumulative release value of 54.0% at pH 7.4, compared to 73.0% for AmCs NPs. The formulated nanoparticles exhibited acceptable biocompatibility and biodegradability. These findings emphasize that Q-AmCs NPs have an outstanding potential for the delivery and slow release of anticancer drugs. 相似文献
2.
Wasim Ul Bari Najeeb Ur Rehman Ajmal Khan Sobia Ahsan Halim Ye Yuan Mark A.T. Blaskovich Zyta M. Ziora Muhammad Zahoor Sumaira Naz Riaz Ullah Amal Alotaibi Ahmed Al-Harrasi 《Molecules (Basel, Switzerland)》2021,26(7)
In the study, two novel compounds along with two new compounds were isolated from Grewia optiva. The novel compounds have never been reported in any plant source, whereas the new compounds are reported for the first time from the studied plant. The four compounds were characterized as: 5,5,7,7,11,13-hexamethyl-2-(5-methylhexyl)icosahydro-1H-cyclopenta[a]chrysen-9-ol (IX), docosanoic acid (X), methanetriol mano formate (XI) and 2,2’-(1,4-phenylene)bis(3-methylbutanoic acid (XII). The anticholinesterase, antidiabetic, and antioxidant potentials of these compounds were determined using standard protocols. All the isolated compounds exhibited a moderate-to-good degree of activity against acetylcholinesterases (AChE) and butyrylcholinesterase (BChE). However, compound XII was particularly effective with IC50 of 55 μg/mL (against AChE) and 60 μg/mL (against BChE), and this inhibitory activity is supported by in silico docking studies. The same compound was also effective against DPPH (2,2-diphenyl-1-picrylhydrazyl) and ABTS (2,2′-azinobis-3-ethylbenzothiazoline-6-sulfonic acid) radicals with IC50 values of 60 and 62 μg/mL, respectively. The compound also significantly inhibited the activities of α-amylase and α-glucosidase in vitro. The IC50 values for inhibition of the two enzymes were recorded as 90 and 92 μg/mL, respectively. The in vitro potentials of compound XII to treat Alzheimer’s disease (in terms of AchE and BChE inhibition), diabetes (in terms of α-amylase and α-glucosidase inhibition), and oxidative stress (in terms of free radical scavenging) suggest further in vivo investigations of the compound for assessing its efficacy, safety profile, and other parameters to proclaim the compound as a potential drug candidate. 相似文献
3.
4.
Zyta Ziora Alina Maly Barbara Lejczak Pawel Kafarski Jolanta Holband Grayna Wjcik 《Heteroatom Chemistry》2000,11(3):232-239
Reaction of commercially available trialkyl phosphites with N‐phthalylamino acids gave mixtures of seven products, whereas the same reaction carried out with pure triethyl phosphite yielded only the desired 2‐(N‐phthalylamino)‐1‐oxoalkanephosphonates. These compounds underwent rearrangement to the same types of products that were obtained with the commercial phosphites. This latter series of reactions was promoted by the presence of dialkyl phosphites. © 2000 John Wiley & Sons, Inc. Heteroatom Chem 11:232–239, 2000 相似文献
5.
Zyta Ziora Alina Maly Barbara Lejczak Paweł Kafarski 《Phosphorus, sulfur, and silicon and the related elements》2013,188(1)
Abstract Reaction of N-blocked amino acid chlorides with trialkyl phosphites is a first step in the synthesis of 2-amino-l-hydroxyalkylphosphonates. Quite surprisingly a very purl trialkyl phosphite is required m order to obtain the desired N-blocked 2-amino-1-oxoalkylphosphonate. Thus, the use of commercially rvailrble phosphites prolongation of the reaction time, or attempts for chromatographic purification of the formed oxophosphonate resulted m quite complicated mixture of products. We haw found that these products arise as a consequence of rearrangements of 1oxo-2. phtalylnmmoalLylphosphonates in a series of reactions which are promoted by that presence of dialkyl phosphite (standard impurity present m commercially availablt trialkyl phosphites) in the reaction medium. 相似文献
1